Search

Your search for "amst" returned the following results.
Filter Results:
InvestorNewsBreaks

InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST) CEO to Participate at Upcoming LD Micro Main Event

September 28, 2023

Amesite (NASDAQ: AMST) CEO Dr. Ann Marie Sastry will be the keynote speaker at the upcoming LD Micro Main Event XVI; LD Micro’s Main Event runs from Oct. 2–5, 2023, in Los Angeles. Amesite is leading artificial intelligence (“AI”) software company offering a cloud-based learning platform for business and education markets. According to the announcement, […]

InvestorNewsBreaks

InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST) Renews Key Partnership with Central Michigan University

August 15, 2023

Amesite (NASDAQ: AMST), a leading artificial intelligence (“AI”) software company offering a cloud-based learning platform for education, business and government markets, has renewed its partnership with Central Michigan University (“CMU”). According to the announcement, the U.S. continuing ed sector is projected to grow from $60.52 billion in 2022 to $93.25 billion by 2028, with a […]

InvestorNewsBreaks

InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST) to Roll Out New LMS Integration Capability

July 25, 2023

Amesite (NASDAQ: AMST), a leading artificial intelligence (“AI”) software company offering a cloud-based learning platform for education, business and government markets, has announced its capability of integrating with Learning Management Systems (“LMS”). The company noted that the new integration will be rolled out across a variety of platforms beginning Aug. 14, 2023, timed to launch […]

InvestorNewsBreaks

InvestorNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Presenting 6 Posters on Its Lead Therapeutic Candidate at AAIC 2023

July 18, 2023

IGC Pharma (NYSE American: IGC), a clinical-stage pharmaceutical company, today announced that it is presenting six in-person posters highlighting data from its phase 1 clinical trials investigating the company’s lead therapeutic candidate, IGC-AD1, at the Alzheimer’s Association International Conference (“AAIC”). The event is taking place July 16-20, 2023, in Amsterdam, Netherlands. “We are honored to […]

InvestorNewsBreaks

InvestorNewsBreaks – INmune Bio Inc. (NASDAQ: INMB) Announces New Findings to Be Presented at Annual AAIC

July 11, 2023

INmune Bio (NASDAQ: INMB), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announced new findings from data to be presented at the annual Alzheimer’s Association International Conference (“AAIC”). Slated to take place in Amsterdam, Netherlands, AAIC is the largest medical meeting focused on Alzheimer’s […]

InvestorNewsBreaks

InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST) CEO Featured in ARK Invest Podcast

July 7, 2023

Amesite (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform for education, business and government markets, today announced that Dr. Ann Marie Sastry participated as a special guest in an ARK Invest Podcast. Dr. Sastry joined hosts Cathie Wood of ARK Invest and Angie Dalton of Signum Growth Capital to delve […]

InvestorNewsBreaks

InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST) Announces Upcoming Launch of AI-Driven Platform V6.3

June 28, 2023

Amesite (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform for education, business and government markets, today announced that V6.3 will be available to its customers on July 10, 2023. “We are thrilled to announce the roll out of our latest update – V6.3 – utilizing a streamlined, AI-first infrastructure. Our […]

InvestorNewsBreaks

InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST) Named Among Michigan’s Best and Brightest for 5th Year Running

June 26, 2023

Amesite (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets, today announced its receipt of an award from the National Association for Business Resources: Michigan’s Best & Brightest in Wellness(R) for the fifth consecutive year. “Maintaining a culture where our highest performers thrive has allowed us […]

InvestorNewsBreaks

InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST) CEO to Participate at ISTELive 2023

June 21, 2023

Amesite (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets, today announced that its founder and CEO Dr. Ann Marie Sastry will be attending ISTELive 2023 on Monday, June 26, 2023. Interested parties should visit https://ibn.fm/JB3wp to request a one-on-one with Dr. Sastry and learn how […]

News Articles

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Expands Focus with Development of New NanoAb Therapeutics

June 20, 2023

Last September, a joint steering committee comprising professionals from BiondVax Pharmaceuticals (NASDAQ: BVXV), the Max Planck Institute for Multidisciplinary Sciences (“MPG”), and the University Medical Center Göttingen (“UMG”), made a decision. Established to guide the BVXV-MPG-UMG NanoAb collaboration, the committee decided to focus the nanosized antibody (“NanoAb”) development on other therapeutic indications in addition to […]

InvestorNewsBreaks

InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST), CMU Partner to Offer Key Professional Upskilling Courses

June 15, 2023

Amesite (NASDAQ: AMST), a leading artificial intelligence (“AI”) software company offering a cloud-based learning platform for business, university, nonprofit and government agency learning and upskilling, has partnered with Central Michigan University (“CMU”) to launch a series of professional upskilling courses. Course topics include an array of titles, from “Introduction to Additive Manufacturing — 3D Printing” […]

InvestorNewsBreaks

InvestorNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Leveraging Big Pharma Competencies to Bring Innovative Therapies to Market Quicker, at Lower Cost

June 12, 2023

BiondVax (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, recently published Q1 2023 financial results and provided a business update. “The Q1 2023 results were in line with analysts’ expectations. R&D expenses increased about $800,000 from Q1 2022, which BiondVax […]

InvestorNewsBreaks

InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST) CEO to Deliver Keynote Address at Upcoming Future of Cybersecurity Summit

June 6, 2023

Amesite (NASDAQ: AMST), a leading artificial intelligence (“AI”) software company offering a cloud-based learning platform for business and education markets, has announced that founder and CEO Dr. Ann Marie Sastry will be giving the opening keynote address at CSO’s Future of Cybersecurity Summit. The event is slated for June 8, 2023; Sastry’s address will begin […]

Press Releases

BiondVax signs exclusive license agreement for development and commercialization of a novel anti-IL-17 antibody for treatment of autoimmune and inflammatory diseases including psoriasis

June 5, 2023

JERUSALEM, June 05, 2023 (GLOBE NEWSWIRE) — via InvestorWire — BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, today announces that as part of its ongoing broad-based collaboration with the Max Planck Society and the University Medical Center Gottingen […]

InvestorNewsBreaks

InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST) to Attend Benzinga All Access Event

June 2, 2023

Amesite (NASDAQ: AMST) will be participating in the live Benzinga All Access event that is scheduled for today. According to the announcement, Amesite CEO Dr. Ann Marie Sastry will present during today’s event; her presentation is scheduled to begin at 11 a.m. ET. Amesite is a leading artificial intelligence software company offering a cloud-based learning […]

InvestorNewsBreaks

InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST), NAFEO Deliver First Pilot Program Through Alliance

May 31, 2023

Amesite (NASDAQ: AMST) and the National Association for Equal Opportunity in Higher Education (“NAFEO”) today announced successful completed delivery of the first pilot program through their alliance. According to the update, Amesite provided the program to Benedict College, a member of the alliance. The cross-campus pilot, through the course Introduction to the World of Digital […]

News Articles

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Receives Buy Rating and $70 Target Price; Releases Q1 2023 and Business Update

May 30, 2023

BiondVax Pharmaceuticals (NASDAQ: BVXV), an innovative biotechnology company developing unique NanoAb immunotherapeutic products for the treatment of infectious disease and large market autoimmune disorders, recently published the financial results for the three months ended March 31, 2023 – Q1 2023 – and provided a business update (https://ibn.fm/GBZmz). The Q1 2023 results were in line with […]

InvestorNewsBreaks

InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST) Renews Partnership with EWIE Group of Companies

May 18, 2023

Amesite (NASDAQ: AMST) is a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets. Amesite today announced that it is extending its partnership with EWIE Group of Companies (“EGC”), a global leader in commodity management services and supply chain optimization with over 30 years of experience. According to the […]

InvestorNewsBreaks

InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST) Updated Platform Includes AI Capabilities, Supports Essential Reskilling of Workers

May 11, 2023

Amesite (NASDAQ: AMST) newest version of its eLearning software, version 6 (“V6”), includes generative artificial intelligence (“AI”) capabilities powered by GPT-4, the technology that supports ChatGPT Plus and Microsoft’s new Bing browser. The company provides its white-label, scalable platform to a range of institutions such as universities, museums, businesses, and government agencies, to help them […]

InvestorNewsBreaks

InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST) Announces Participation at Upcoming Sidoti Virtual Investor Conference

May 10, 2023

Amesite (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets, will be part of the Sidoti May Micro-Cap Virtual Conference, which is slated for May 10–11, 2023. The company announced that its founder and CEO Dr. Ann Marie Sastry will present during the two-day event. Sastry’s […]

InvestorNewsBreaks

InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST) Renews Partnership with Michigan Works! Southeast

April 27, 2023

Amesite (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets, today announced it is extending its partnership with Michigan Works! Southeast (“MWSE”), a longtime leader in upskilling the workforces of Southeast Michigan. The continued partnership will deliver upskilling needs, specifically training on artificial intelligence technologies for the Michigan workforce on MWSE’s proprietary […]

News Articles

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Presents Innovative Pipeline of Nanosized Antibody Treatments at Bio-Europe Spring Conference in Switzerland

April 18, 2023

The EBD Group’s 17th annual Bio-Europe Spring Conference was held March 20-22, 2023, in Basel, Switzerland. The conference showcased three thematic pillars – the business of biotech, therapeutic insight tracks, and ecosystem influencers. The elite European bio-tech conference featured a mix of keynotes from life science executives, fireside chats, panel discussions, and presentations that allowed […]

InvestorNewsBreaks

InvestorNewsBreaks – Amesite Inc.’s (NASDAQ: AMST) Platform, Generative AI Helping Customers Deliver Education Offerings at Scale

April 17, 2023

Amesite (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets, is setting up key partnerships with universities to provide upskilling and reskilling courses to their students. The company recently expanded its alliance with the National Association for Equal Opportunity in Higher Education (“NAFEO”), the college membership […]

InvestorNewsBreaks

InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST) CEO Serving as Panelist at National Action Network 2023 Convention

April 14, 2023

Amesite (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets, announced that its founder and CEO Dr. Ann Marie Sastry is serving as a panelist at the National Action Network 2023 Convention on Friday, April 14, 2023, representing National Association for Equal Opportunity in Higher Education […]

News Articles

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) CEO Discusses Positive Results from In Vivo Proof-of-Concept Study of Its Anti-COVID-19 NanoAb Therapy and Additional Pipeline Plans at BIO-Europe Spring

April 14, 2023

Amir Reichman, CEO of biotechnology company BiondVax Pharmaceuticals (NASDAQ: BVXV), recently presented at the 17th annual BIO-Europe Spring conference in Basel, Switzerland. Hosted by EBD Group, the three-day in-person conference, which was held March 20-22, brought together more than 2,800 executives from biotech, pharma, and finance companies. It not only featured presentations and exhibits from […]

InvestorNewsBreaks

InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST) CEO to Attend ASU+GSV Summit

April 13, 2023

Amesite (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets, will be represented at the upcoming ASU+GSV Summit. The company announced that Amesite founder and CEO Dr. Ann Marie Sastry will be attending the ASU+GSV Summit; she will also be available for one-on-one meetings with other […]

InvestorNewsBreaks

InvestorNewsBreaks – BiondVax Pharmaceuticals Ltd.’s (NASDAQ: BVXV) Lead NanoAb Candidate Holds Significant Advantages to Existing Therapies

April 3, 2023

BiondVax (NASDAQ: BVXV), which focuses on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, has shown, through an ongoing in vivo preclinical proof-of-concept study, that its lead NanoAb candidate for the treatment of COVID-19 exhibits clear competitive advantages over existing monoclonal antibodies (“mAbs”) and oral therapies. “According […]

InvestorNewsBreaks

InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST) Launches V6 Platform Featuring GPT-4 Powered Functionality

April 3, 2023

Amesite (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets, today unveiled its Version 6.0 platform with enhanced and new features. With expanded AI capabilities, the platform is powered by GPT-4 – the same technology behind ChatGPT Plus and Microsoft’s New Bing. “Advancements in generative AI […]

InvestorNewsBreaks

InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST) Announces Expansion of Member Universities to NAFEO Alliance

March 30, 2023

Amesite (NASDAQ: AMST) is a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets. The company today announced that new member universities have joined its collaborative alliance with the National Association for Equal Opportunity in Higher Education (“NAFEO”), the membership and advocacy association of all Historically Black Colleges and […]

InvestorNewsBreaks

InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST) Eyes Opportunity as a Frontrunner for Integrating ChatGPT

March 20, 2023

Amesite (NASDAQ: AMST), a Detroit-based AI software company, has set out the progress it has made in integrating generative AI into its platform. The release of ChatGPT has showcased capabilities and potential of generative AI, which can produce increasingly sophisticated original content. Companies like Amesite that have exposure to generative AI and e-learning sectors could […]

InvestorNewsBreaks

InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST) Delivering FERPA and COPPA-Compliant Learning Programs

March 15, 2023

Amesite (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets, today announced that its white-label platform is delivering COPPA and FERPA-compliant learning programs for its partners around the nation. Designed to protect children’s safety and personal data, requirements call for parental consent for children under the […]

InvestorNewsBreaks

InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST) Releases Statement Regarding No Accounts with, Relationship to Silicon Valley Bank

March 14, 2023

Amesite (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform that delivers 99% learner retention for business and education markets, has announced that it does not hold any cash or contain any accounts at Silicon Valley Bank (“SVB”). The company also noted that it has no current or past business relationship […]

InvestorNewsBreaks

InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST) Regains Compliance with NASDAQ Minimum Bid Price, Other Listing Requirements

March 10, 2023

Amesite (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform that delivers 99% learner retention for business and education markets, has received notice that it has regained compliance with NASDAQ’s minimum bid price requirement of $1.00 per share. The notice also stated that the company meets the stockholders’ equity requirement and […]

InvestorNewsBreaks

InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST) CEO Expands Company Owned Stock with Series of Recent Purchases

March 7, 2023

Amesite (NASDAQ: AMST) CEO Ann Marie Sastry has made multiple stock purchases in AMST, an artificial intelligence (“AI”) software company that offers leading eLearning opportunities. According to the Form 4 filed with the Securities and Exchange Commission (“SEC”), Sastry acquired 2,000 shares of common stock, each at $3, for the purchase price of $6,000. This […]

InvestorNewsBreaks

InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST) Partners with Benedict College to Launch Technology Upskilling Pilot Program

March 2, 2023

Amesite (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform that delivers 99% learner retention for business and education markets, has announced an upskilling pilot project in partnership with Benedict College. According to the announcement, the pilot leverages GPT-3, the latest technological disruptor that powers ChatGPT, through the Amesite platform; the […]

InvestorNewsBreaks

InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST) to Provide Video Update for Shareholders

February 27, 2023

Amesite (NASDAQ: AMST) is a leading artificial intelligence software company offering a cloud-based learning platform that delivers 99% learner retention for business and education markets. The company today announced that it will be posting a video shareholder update to its website at 1:00 PM ET on Monday, Feb. 27, 2023. Shareholders should visit https://ibn.fm/Qq6nf to […]

News Articles

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) and Its Collaborators Are Positioned to Rapidly Develop COVID-19 Treatments to Neutralize Emerging Variants

February 24, 2023

The Food and Drug Administration (“FDA”) has, over the last two years, authorized several drugs as treatments for mild-to-moderate COVID-19 or as pre-exposure prophylaxis (“PrEP”) for the prevention of the disease. Most of these drugs were based on human monoclonal antibody (“mAb”) technology and were designed to boost the immune system by mimicking natural neutralizing […]

InvestorNewsBreaks

InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST) Shareholders Approve 1-for-12 Reverse Stock Split, Effective Today

February 22, 2023

Amesite (NASDAQ: AMST), a leading artificial intelligence (“AI”) software company offering a cloud-based learning platform for education, business and government markets, will effect a 1-for-12 reverse split of its common stock; the reserve split was effective today at open of business. According to the announcement, AMST common stock will trade on a post-split basis on […]

InvestorNewsBreaks

InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST) Unveils Free Course to Teach Fundamentals of ChatGPT

February 21, 2023

Amesite (NASDAQ: AMST), a leading artificial intelligence (“AI”) software company offering a cloud-based learning platform for education, business and government markets, has launched ChatGPT Fundamentals, a free course available on AmesiteEngage, the company’s Learning Community Environment(R). The course will be free to the first 1,000 people who register. According to the announcement, course curriculum covers the […]

InvestorNewsBreaks

InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST) Launches First Pilot Program Under NAFEO Alliance

February 16, 2023

Amesite (NASDAQ: AMST) and the National Association for Equal Opportunity in Higher Education (“NAFEO”), today announced the launch of the first pilot program through their alliance. Amesite is providing the cross-campus pilot, which offers upskilling in technology, including internet protocols, data privacy and security and cloud computing, to Benedict College, a member of the alliance. […]

No ResultsNo content matches your search/filter.

 

 

 

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(310) 299-1717

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).